Lakewood-Amedex Biotherapeutics Inc.
LABT· Nasdaq
LABTLakewood-Amedex Biotherapeutics Inc.
Filed May 22, 2026 · 10-Q · 52 days after period end · 0001213900-26-060640
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | -$923.29K | -$539.62K |
| EPS Diluted | -$0.20 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2026 · filed May 22, 2026 · 52 d after period end
Lakewood-Amedex Biotherapeutics Inc. · CIK 2079272 · Engraved from SEC EDGAR
